Preprint Brief Report Version 1 Preserved in Portico This version is not peer-reviewed

Can Innate Immunity Flatten the Curve? Covid-19 – A Case Study

Version 1 : Received: 19 April 2020 / Approved: 19 April 2020 / Online: 19 April 2020 (16:54:43 CEST)

How to cite: Banerjee, S. Can Innate Immunity Flatten the Curve? Covid-19 – A Case Study. Preprints 2020, 2020040353 (doi: 10.20944/preprints202004.0353.v1). Banerjee, S. Can Innate Immunity Flatten the Curve? Covid-19 – A Case Study. Preprints 2020, 2020040353 (doi: 10.20944/preprints202004.0353.v1).

Abstract

We have proposed a model considering two equally sized population (group A and group B) with low and high levels of disease tolerance. We have argued that in the more tolerant group (group B) the progression of the disease with respect to time will be slow with lower number of infections at any given time. We attribute this effect to the innate immunity which advantageously, can also be one of the major contributing factors for flattening the curve. We have compared the growth of Covid-19 disease in various countries to understand this effect.

Subject Areas

COVID-19; innate immunity

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.